IP Verse

Accord Healthcare opposition analysis

COMPANY ANALYSIS

Latest oppositions filed by Accord Healthcare

Patent Number:
EP2493466
Title:
Novel Antitumoral Use Of Cabazitaxel
Applicant:
AVENTIS PHARMA S.A.
Opposition Date:
Aug 30, 2024
Patent Number:
EP3263106
Title:
Method For Suppressing Bitterness Of Quinoline Derivative
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
Jul 25, 2024
Patent Number:
EP3883606
Title:
Safe And Effective Method Of Treating Ulcerative Colitis With Anti-Il12/Il23 Antibody
Applicant:
JANSSEN BIOTECH, INC.
Opposition Date:
Apr 12, 2024
Patent Number:
EP2687202
Title:
Subcutaneous Anti-Her2 Antibody Formulation
Applicant:
F. HOFFMANN-LA ROCHE AG
Opposition Date:
Feb 12, 2024
Patent Number:
EP3324936
Title:
Method For Producing A Bortezomib Ester Solution
Applicant:
STADA ARZNEIMITTEL AG
Opposition Date:
Jun 28, 2023
Patent Number:
EP3324937
Title:
Ready-To-Use Bortezomib Solution
Applicant:
STADA ARZNEIMITTEL AG
Opposition Date:
May 17, 2023
Patent Number:
EP3524595
Title:
High-Purity Quinoline Derivative And Method For Manufacturing Same
Applicant:
EISAI R&D MANAGEMENT CO., LTD.
Opposition Date:
May 10, 2023
Patent Number:
EP2653873
Title:
Compositions And Uses For Treating Multiple Sclerosis
Applicant:
BIOGEN IDEC MA INC.
Opposition Date:
Apr 18, 2023
Patent Number:
EP2959894
Title:
S1P Receptor Modulators For Treating Multiple Sclerosis
Applicant:
NOVARTIS AG
Opposition Date:
Dec 1, 2022
Patent Number:
EP3725778
Title:
Formulations Of Enzalutamide
Applicant:
ASTELLAS PHARMA INC.
Opposition Date:
May 18, 2022

Competitors of Accord Healthcare

NOVARTIS AG

AMGEN INC.

AMGEN, INC

Want to track Accord Healthcare?

Feel free to send us a message here and we will get back to you